Varenicline reduced smoking behaviour in a mentally ill person.

Abstract

Sirs – Varenicline, a partial agonist of α4β2-neuronal nicotinic acetylcholine receptors (nAChRs), is efficacious for smoking cessation (Coe, et al., 2005a). It is superior to both placebo and bupropion (Jorenby, et al., 2006). The varenicline registration trials have excluded mentally ill people from their study populations (Jorenby, et al., 2006) despite… (More)
DOI: 10.1177/0269881108089601

Topics

1 Figure or Table

Cite this paper

@article{Ochoa2009VareniclineRS, title={Varenicline reduced smoking behaviour in a mentally ill person.}, author={Enrique L. M. Ochoa}, journal={Journal of psychopharmacology}, year={2009}, volume={23 3}, pages={340-1} }